Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

NCT00358696 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV
HIV Infections

Interventions

DRUG: tenofovir

Sponsor

University of British Columbia

Collaborators

[object Object]